Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06925334 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus

Study acronym: TLI vs PMI
StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 13, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A randomized open, positive parallel controlled clinical study design was adopted. Participants were randomly assigned 1:1 according to inclusion criteria and exclusion criteria into two treatment regiments: Delu insulin liraglupeptide injection group and premixed insulin (or premixed insulin analogue). After fasting blood glucose was controlled at 7.5mmol /l in the morning, blood glucose was monitored by CGM (14d), and the Time in Range (3.9-10 mmol/l) was compared. Glycated albumin was measured and stool samples were taken before treatment and at 4 weeks.
Trial Details
NCT Number NCT06925334
Lead Sponsor Beijing Tsinghua Chang Gung Hospital
Collaborators: Taizhou First People's Hospital, Wenzhou Central Hospital, Wenzhou People's Hospital, Chaohu Hospital of Anhui Medical University, Affiliated Zhoushan Hospital of Wenzhou Medical University, Yiwu Central Hospital, Jinhua Municipal Central Hospital, Dongyang People's Hospital, The Central Hospital of Lishui City, Affiliated Hospital of Jiaxing University, Jinhua People's Hospital, Wuhu City Second People's Hospital, Affiliated Hospital of Nantong University
Conditions
(from sponsor)		 Type 2 Diabetic Patients
Enrollment 170 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov